Home News

Five Reasons Why Drug Rebates Are Harmful to Patients and to the Healthcare System

September 1, 2020

By William Smith

This report shows that ever-larger rebates are distorting the market for branded drugs and producing outcomes that often benefit neither consumers nor the healthcare system.

Download the report: Five Reasons Why Drug Rebates Are Harmful to Patients and to the Healthcare System (2 downloads )

Education

August 26, 2020

MA’s Remote Learning Regs Should Specify Consistent District Grading Policies, Return of MCAS in 2020-21

Healthcare

September 1, 2020

Featured

Featured

Five Reasons Why Drug Rebates Are Harmful to Patients and to the Healthcare System

MA’s Remote Learning Regs Should Specify Consistent District Grading Policies, Return of MCAS in 2020-21

Study: Growing Drug Rebates Hurt Both Consumers and Healthcare System

Sign Up For Our Newsletter

Featured

Featured

MA’s Remote Learning Regs Should Specify Consistent District Grading Policies, Return of MCAS in 2020-21

Study: Growing Drug Rebates Hurt Both Consumers and Healthcare System

Related Publications

State Report Card on Telehealth Reform: Incremental Progress in 2025 Leaves Many States Unprepared for Rural Health Transformation Funding

Study Rates Every State’s Telehealth Laws for Patient Access and Ease of Providing Services

Study Finds Trump’s Most Favored Nation Drug Proposal Could Still Raise Out-of-Pocket Costs Without PBM Reform

Pioneer Institute Launches Tracker Showing Drug Price Controls Are Raising Out-of-Pocket Costs for Medicare Patients

Sign Up For Our Newsletter